Pfizer biontech - activities

Covid: Indian Bharat Biotech’s vaccine Covaxin approved by the WHO

This Wednesday November 3, the WHO has announced they have emergency approved a brand-new Covid vaccine, Covaxin, developed by Indian biotech Bharat Biotech. According to the World Health Organization, the vaccine is 78% effective against the virus, requiring two injections four weeks apart.

Covid: third dose of Pfizer 95.6% effective against the virus, the laboratory claims

Pfizer-BioNTech has carried out a study showing their booster shot is 95.6% effective against symptomatic Covid-19.

Coronavirus vaccine in teenagers: Moderna vaccine allowed for 12-17 years old

In France, Moderna Covid vaccine is now approved by the Haute Autorité de Santé to be used in vaccinating teenagers aged 12 to 17. A decision following the prior approval released by the European Medicines Agency.

Vaccinees no longer considered as contact cases, according to Jean Castex

As vaccination has opened to all since May 2021, more and more French are fully vaccinated! But should vaccines still have to self-isolate if they have been in contact with someone infected with Covid-19? Not anymore, according to Prime Minister Jean Castex who announced this Wednesday July 21 self-isolation was no longer compulsory. Olivier Véran is to tell more on the matter in the afternoon.

Pfizer vaccine: does the second dose cause more side effects?

Headache, fever, shivers, fatigue… More and more French are complaining about disturbing side effects after they have been given the second dose of the Pfizer – BioNTech vaccine. According to doctors, there is nothing to be worried about.

Covid: WHO approves Moderna’s vaccine for emergency use

This Friday April 30, WHO announced they have approved Moderna’s vaccine for emergency use. Good news for disadvantaged countries.

Covid: Pfizer to develop two treatments against the virus

Two treatments against Covid are being studied, but have delivered encouraging primary results… This is what Pfizer France director David Lepoittevin announced this Friday April 9, stating that one of them was to be given orally, the other one intravenously. Two medicines that – if trials show effectiveness – could complete the existing arsenal amid the fight against coronavirus.

Pfizer vaccine: booster shots likely to be needed, the laboratory warns

Because of Covid-19 variants and to guarantee longer immunity to people vaccinated with the Pfizer solution, the laboratory CEO warned that booster shots were likely to be needed by six to twelve months, then followed by one shot every year.

Pfizer: France has launched the vaccine production in the country

According to news from our peers from Journal du Dimanche, the manufacturing of the Pfizer/BioNTech vaccine is to begin in France, at Delpharm, an expert in packing pharmaceutical product, starting Wednesday April 7. This is the very first Covid vaccine produced in France. In all 250 million doses are to be issued by the end of the year, according to Industry Minister Agnès Pannier-Runacher.

Covid: Novartis to help Pfizer manufacturing their vaccine in Europe

This Friday January 29, after Sanofi, it is now Novartis laboratories’ turn to announce they have a deal with Pfizer to help them manufacture their vaccine. Goal? Getting round the lack hitting countries, as deliveries are lagging behind.

Covid: Sanofi to help Pfizer producing vaccine in Europe

This Tuesday January 26, in the evening, French laboratory Sanofi announced they will help rival Pfizer producing their vaccine in Europe as they are behind elaborating theirs. All in all, over 100 million doses are to be manufactured in Frankfurt by the end of 2021.

Covid vaccine: six severe allergy cases reported in France, the ANSM says

This Thursday January 14, the ANSM - the French Agency for the Safety of Health Products - said they have been reporting six cases of severe allergy to Pfizer Covid vaccine in France. This statement completes Health Minister Véran's - made on Tuesday January 12 - as he announced a case of “an adverse effect of an allergic nature” has been identified following Covid vaccine injection.

Pfizer/BioNTech vaccine, the number of doses given differs from country to country

Barely started and Pfizer/BioNTech vaccine is once again at the heart of debates! After side effects, sometimes very severe noticed in some patients that have had allergic reactions, it is now required to agree on the number of doses to inject to each person! As the United-Kingdom has decided to vaccinate as many people as possible with one dose per patient, France recommends a two-dose vaccine, said to be more effective.

Coronavirus: Chinese Sinopharm vaccine’s effectiveness

As vaccine campaigns have started around the globe, Sinopharm unveils the effectiveness of their vaccine. It is the first Chinese laboratory to share these data.

Covid vaccine: first allergic reactions noticed in the United-Kingdom

As the Covid vaccine campaign has recently begun in the United-Kingdom, the authorities have had to warn after two caregivers, barely vaccinated, have shown a severe allergic reaction to the vaccine. Two people with severe allergic reaction history.

AstraZeneca Covid vaccine “safe and effective” The Lancet says

Is AstraZeneca covid vaccine safe and effective against the virus as well? This is what seem to say results from the analysis published in medical journal The Lancet. Results have been peer-reviewed and the vaccine is said to be about 70% effective.

Covid vaccine: Pfizer seeks approval for issuing in Europe

Covid vaccine soon to be on the market… After Moderna Therapeutics, it is now Pfizer and BioNTech seeking approval for issuing their vaccine in Europe. An application said to be examined by the European Medicines Agency by December 29, 2020.